Back to results
US 2006/0276529 A1Published application
Use of plasma membrane calcium atpase (pmca) inhibitors for inhibiting sperm mobility
OwnerLudwig Neysesinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of plasma membrane calcium ATPase (PMCA) inhibitors for inhibiting sperm mobility to achieve a contraceptive effect. The invention further relates to contraceptive agents comprising one or more PMCA inhibitors.
Claims11
1-13. (canceled)
A method of achieving a contraceptive effect comprising administering an inhibitor directed against a plasma membrane calcium ATPase 4 (PMCA4) isoform, thereby inhibiting sperm mobility.
Dependencies are inferred from the claim text.